ORMD-0801 explained

ORMD-0801 is an experimental insulin analog that is taken by mouth, rather than injected. It is developed by Oramed Pharmaceuticals to treat diabetes.^{[1] [2] [3] [4]}

Notes and References

1. Eldor . Roy . Arbit . Ehud . Corcos . Asher . Kidron . Miriam . Glucose-Reducing Effect of the ORMD-0801 Oral Insulin Preparation in Patients with Uncontrolled Type 1 Diabetes: A Pilot Study . PLOS ONE . 9 April 2013 . 8 . 4 . e59524 . 10.1371/journal.pone.0059524 . 23593142 . 3622027 . 2013PLoSO...859524E . en . 1932-6203 . free .
2. Eldor . Roy . Neutel . Joel . Homer . Kenneth . Kidron . Miriam . Efficacy and safety of 28-day treatment with oral insulin (ORMD -0801) in patients with type 2 diabetes: A randomized, placebo-controlled trial . Diabetes, Obesity and Metabolism . November 2021 . 23 . 11 . 2529–2538 . 10.1111/dom.14499. 34310011 . 236432013 .
3. Eldor . Roy . Fleming . G. Alexander . Neutel . Joel . Homer . Kenneth E. . Kidron . Miriam . Rosenstock . Julio . 1004-P: Oral Insulin (ORMD-0801) Effects on Glucose Parameters in Uncontrolled T2DM on OADs . Diabetes . 1 June 2020 . 69 . Supplement_1 . 10.2337/db20-1004-P. 225845842 .
4. Eldor . Roy . Francis . Bruce H. . Fleming . Alexander . Neutel . Joel . Homer . Kenneth . Kidron . Miriam . Rosenstock . Julio . Oral insulin (ORMD -0801) in type 2 diabetes mellitus: A dose-finding 12-week randomized placebo-controlled study . Diabetes, Obesity and Metabolism . April 2023 . 25 . 4 . 943–952 . 10.1111/dom.14901. 36281496 . 253108516 .